Derma Sciences gets CE Mark For Algicell Ag

derma sciencesDerma Sciences has received CE mark for Algicell Ag wound dressings for use in the EU. Algicell Ag is an antimicrobial silver alginate dressing that delivers 1.4% ionic silver at a slow consistent release rate for broad-spectrum efficacy. Derma Sciences claimed that Algicell Ag provides advanced bactericidal action with kill rates of approximately 99.99%, while absorbing approximately 16% more exudates than the leading competitive product.

Read the full story here

Solta Medical Launches New Fraxel re:store(R) Dual Laser System

Solta MedicalSolta Medical, Inc. has announced its European launch of the Fraxel re:store Dual laser system with the recent CE Mark approval. The new Fraxel re:store Dual system is optimized for both facial procedures and large body areas to address clearance of pigmentation and other skin conditions all in a single treatment. This CE Mark joins the registration obtained in September for Solta Medical’s Thermage CPT, the most advanced non-invasive skin tightening and contouring procedure.

Syneron(TM) Unveils Elegant, Portable eMatrix(TM) Skin Resurfacing System

Syneron(TM) Medical Ltd. has launched the sleek eMatrix(TM) treatment system, a portable touch-screen device that allows physicians to program dermatological procedures requiring skin resurfacing. An exciting advancement in aesthetic procedure technology that helps physicians to treat more patients in more locations, eMatrix utilizes Matrix RF(TM), the world’s first RF-only technology for fractional ablation and skin resurfacing, which was FDA-cleared and received the CE Mark for wrinkle reduction in August. The new eMatrix system uses fractional tissue heating to provide ablation and effective resurfacing.

Biocompatibles Filing For CE Mark Approval For Dermal Filler Bead

Biocompatibles has announced the filing for CE Mark approval by the Company’s development and marketing partner Merz Pharmaceuticals GmbH for the Cosmetic Dermal Filler Bead. The product has been licensed to Merz and will be manufactured by Biocompatibles’ German subsidiary, CellMed AG. The global market for aesthetic dermal filler products1 is at least $760m2. The current market consists mainly of products manufactured from collagen and hyaluronic acid. Biocompatibles’ subsidiary CellMed manufactures the Cosmetic Dermal Filler Bead from highly purified alginate material, using a proprietary manufacturing process.

Eleme Medical receives CE Mark for SmoothShapes®

Elemé™ Medical Inc. has received CE Mark approval for its SmoothShapes® System. The SmoothShapes® System uses a proprietary technology called Photomology® that combines laser and light energy with mechanical massage and vacuum. The system restores healthy activity of adipose cells. The treatment provides improved appearance of cellulite that lasts longer. The device that has already received a clearance from FDA will be launched by the company at the 17th Congress of the European Academy of Dermatology & Venereology in Paris.